NCT06891690 Use of TDCS Stimulation in Neurological and Gynaecological Conditions
| NCT ID | NCT06891690 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Poznan University of Physical Education |
| Condition | Stroke |
| Study Type | INTERVENTIONAL |
| Enrollment | 300 participants |
| Start Date | 2025-02-05 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 300 participants in total. It began in 2025-02-05 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of the study is to test the effect of tDCS stimulation on upper and lower limb function in neurological patients and to reduce pain in gynaecological patients. And the impact of tDCS stimulation on patients' quality of life. Standardised questionnaires will be used for pre- and post-stimulation evaluation.
Eligibility Criteria
Neurological patients Inclusion Criteria: * impairment of upper and lower limb function. Exclusion Criteria: * no written consent to participate in the study. Gynaecological patients Inclusion Criteria: * women with selected gynaecological conditions (endometriosis, painful menstruation, dyspareunia, polycystic ovary syndrome) with no treatment other than tDCS stimulation. Exclusion Criteria: * no written consent to participate in the study.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06891690 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 90 Years, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06891690 currently recruiting?
Yes, NCT06891690 is actively recruiting participants. Contact the research team at m.wojcik@awf-gorzow.edu.pl for enrollment information.
Where is the NCT06891690 trial being conducted?
This trial is being conducted at Poznan, Poland.
Who is sponsoring the NCT06891690 clinical trial?
NCT06891690 is sponsored by Poznan University of Physical Education. The trial plans to enroll 300 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.